Showing results (501-510 of 515) with videos related to

Sort By:
Pageof 52
Crohn'S & Colitis 360|May 12, 2026
Comparison of IBD-related outcomes in patients with obesity treated with GLP-1 receptor agonists versus bariatric surgeryM Housam Nanah, Arjun Chatterjee, Hisham Wehbe, et al.
Crohn'S & Colitis 360|May 4, 2026
Treatment outcomes of prolonged induction or re-escalation dosing of upadacitinib in patients with inflammatory bowel diseaseEllen Axenfeld, Vasantham Chaudhary, Joseph W Clinton, et al.
Crohn'S & Colitis 360|April 21, 2023
Role and Impact of a Clinical Pharmacy Team at an Inflammatory Bowel Disease CenterDavid K Choi, David T Rubin, Archariya Puangampai, et al.
Crohn'S & Colitis 360|July 16, 2026
The PANACEA Project: a multinational model for digital health literacy in inflammatory bowel diseaseViviana Parra Izquierdo, Beatriz Iade Vergara, Marta Benner Machado, et al.
Crohn'S & Colitis 360|July 30, 2026
Impact of pediatric versus adult diagnosed inflammatory bowel disease on achievement of health care autonomy in emerging adults: a cross-sectional studyAllison Bihari, Cynthia H Seow, Eytan Wine, et al.
Crohn'S & Colitis 360|August 4, 2026
Comparative effectiveness of adalimumab versus infliximab in children with Crohn's disease: real-world data from the prospective PIBD-SETQuality inception cohort studyStephanie A Vuijk, Renz C W Klomberg, Eva Katgert, et al.
Crohn'S & Colitis 360|July 30, 2026
Disability among Palestinian patients with inflammatory bowel disease: evaluation using the IBD Disk and identification of associated factorsAhmed Quraish, Ro'ya Khanfar, Karmil Kharouf, et al.
Crohn'S & Colitis 360|August 23, 2026
Most of moderate to severe ulcerative colitis patients in academic clinical practice still do not qualify for randomized controlled trialsSandra Elmasry, Shabana Pasha, Manreet Kaur, et al.
Crohn'S & Colitis 360|August 30, 2026
Outcomes of tofacitinib dose reduction in patients with ulcerative colitis in stable remission: a long-term follow-up of the randomized RIVETING trialDavid T Rubin, Julian Panés, Joana Torres, et al.
Crohn'S & Colitis 360|August 28, 2026
FUT2 non-secretor status is not associated with disease phenotype or outcomes in patients with Crohn's diseaseRachel Lombard, Wenfei Wang, Alexander Chervonsky, et al.
Pageof 52